Search PubMed⌕ Search

Biomedical subjects

H Tokunaga

Publications and source records attributed to H Tokunaga.

At least 127 records · Page 7Linked to original sources

[Result of surgical treatment in 226 cases of primary lung cancer].

From August, 1979 to June, 1990, 226 cases of primary lung cancer were treated surgically at our Department. Of these, 176 cases, excluding hospital deaths from lung cancer and other diseases, were analyzed according to prognosis. The 5-year survival rate of the 176 cases was 40.2% and the 5-year survival rates according to sex were, male, 36.1%; female, 53.2%. The 5-year survival rates according to postoperative stage were, stage I, 64.1%; stage II, 44.1%; stage III A, 22.1%; stage III B & IV, 0% and the 5-year survival rates according to histologic type were, adenocarcinoma, 40.5%; squamous cell carcinoma, 49.7%; large cell carcinoma, 18.9%; small cell carcinoma, 0%. The 5-year survival rates according to primary site were, right side, 43.8%; left side, 34.6%; right upper lobe, 39.7%; right middle lobe, 60.0%; right lower lobe, 44.4%; left upper lobe, 41.7%; left lower lobe, 18.1%. The prognosis of squamous cell carcinoma, and the early stage, female group, right side group, right middle & lower lobe group, were all fairly good.

Adenocarcinoma↗

[A case report of chronic traumatic dissecting aneurysm of the thoracic aorta].

A 63-year-old male, who sustained a blunt chest trauma in a traffic accident, was referred to our hospital for his traumatic aneurysm. An operative repair was undertaken 3 months after the trauma. The descending aorta was dissected along 5 cm, and its diameter was about 6 cm. Graft replacement was performed under the left heart bypass by using the BioMedicus centrifugal pump. He is doing well 3 years after the operation.

Accidents, Traffic↗

[A case report of silent right atrial myxoma].

A 68-year-old man with right atrial myxoma detected by abdominal echography accidentally is reported. The diagnosis was confirmed by use of echocardiography and MRI. Selective coronary angiography visualized the tumor vessels. The myxoma was removed successfully. The origin of the tumor was the free wall of the right atrium, and its weight was 14 g.

Aged↗

Eosinophilic neuronal inclusion bodies in the temporal lobe.

Intracytoplasmic neuronal inclusion bodies were found in the temporal lobe of an elderly woman. The oval or rod-shaped inclusion bodies were eosinophilic, showed bright red staining with azan, and were about half the size of the nucleus of a large neuron. They were non-argyrophilic and non-congophilic. Ultrastructurally, the inclusion bodies consisted of aggregates of filamentous materials showing partial periodicity. Among inclusion bodies reported up to now, the present ones resembled some described previously as "thalamic inclusions", but were different with regard to their partial filament periodicity, and unusual in that they were located in the deep layer of the temporal lobe and not in the thalamic nuclei.

Actins↗

[Chlormadinone Acetate Reference Standard (Control 881) of National Institute of Hygienic Sciences].

Chlormadinone acetate was tested for the preparation of the "Chlormadinone Acetate Reference Standard (Control 881)". Analytical data obtained were as follows: loss on drying, 0.00%; infrared spectrum, 1740, 1715, 1658, 1604, 1587, 1256, 1244 cm-1; ultraviolet spectrum, lambda max = 284 nm; absorbance, E1cm1% (284 nm) = 539-549; optical rotation, [alpha]D20: -12.1 degrees; melting point, 214.6 degrees C; thin-layer chromatography, contaminants were not detected until 300 micrograms; high-performance liquid chromatography, one contaminant was detected. On the basis of the above results, this material was authorized as the National Institute of Hygienic Sciences Reference Standard (Control 881).

Chlormadinone Acetate↗

[Tocopherol Succinate Reference Standard (Control 881) of National Institute of Hygienic Sciences].

Tocopherol succinate was tested for the preparation of "Tocopherol Succinate Reference Standard (Control 881)". Analytical data obtained were as follows: infrared spectrum, same as Tocopherol Succinate Reference Standard (Control 851); absorbance, E1cm1% (286 nm) = 40.5; thin-layer chromatography, contaminants were not detected until 50 micrograms; high-performance liquid chromatography, three contaminants were detected; loss on drying, 0.09%; assay, 100.0%. On the basis of the above results, this material was authorized as the Japanese Pharmacopoeia Standard (Control 881).

Chromatography, High Pressure Liquid↗

[Methyldigoxin Reference Standard (Control 881) of National Institute of Hygienic Sciences].

Methyldigoxin was tested for preparation of the "Methyldigoxin Reference Standard (Control 881)". Analytical data obtained were as follows: infrared spectrum 3456, 1738, 1086 cm-1; ultraviolet spectrum lambda max = 219 nm; absorbance E1cm1% (219 nm) = 193.1; water 0.99%; optical rotation [alpha]546.1(20) = +22.5 degrees; thin-layer chromatography and high-performance liquid chromatography indicates two impurities, respectively; quantitative analysis of acetone 3.87%; assay by spectrophotometry 100.3% against Digoxin Reference Standard (Control 802). On the basis of the above results, this material was authorized as the National Institute of the Hygienic Sciences Reference Standard (Control 881).

Chromatography, High Pressure Liquid↗

[Cholecalciferol Reference Standard (Control 871) of National Institute of Hygienic Sciences].

Cholecalciferol Reference Standard (Control 871) for the Japanese Pharmacopoeia was prepared. The following analytical data were obtained: melting point, 86.3 degrees C; infrared spectrum, same as the Japanese Pharmacopoeia Standard "Cholecalciferol Standard (Control 851)"; absorbance, E1%1cm (265 nm) = 474.5; optical rotation, [alpha]20D = + 110.0 degrees; thinlayer chromatography, same as the Japanese Pharmacopoeia Standard; highperformance liquid chromatography, contaminants were not detected; assay, 100.7%. On the basis of those results, this material was authorized as the Japanese Pharmacopoeia Standard (control 871).

Chemical Phenomena↗

Mercury level and histochemical distribution in a human brain with Minamata disease following a long-term clinical course of twenty-six years.

Details are given of the mercury level and deposition in a human brain with Minamata disease following a twenty-six year clinical course after the first severe attack in 1956. This is the first report of a case in which the methylmercury level within the brain has returned to normal limits in a severely affected victim. However, the total mercury remained high in the brain, and mercury was clearly demonstrated histochemically in microglial cells or macrophages over wide areas of the brain and in neurons of specific brain areas. Bergmann's glial cells also contained mercury deposits, whereas Purkinje's cells had relatively little or no deposition. Mild deposition of the metal was demonstrable in the epithelial cells of the choroid plexus.

Aged↗

[A case of successful surgical treatment of straddling tricuspid valve associated with dextrocardia and VSD].

A case of straddling tricuspid valve associated with dextrocardia and VSD was presented. Closure of ventricular septal defect and tricuspid valve replacement were performed on this patient. Since the straddling septal leaflet of the tricuspid valve shared a posterior papillary muscle in the left ventricle with the posterior mitral leaflet, division of this papillary muscle was thought to induce papillary muscle dysfunction of both leaflet. Hence, the chordae of straddling tricuspid leaflet was detached from the shared papillary muscle and the ventricular septal defect was closed by a large pericardial patch. Because of peculiar anatomy of the conduction system in this situation, the junctional area of the inlet septum and tricuspid annulus was avoided from stitching in VSD closure. Suture through the tricuspid septal leaflet and pericardial patch for VSD were used for tricuspid valve replacement as well. The patient showed uneventful postoperative course without any conduction disturbance including the right bundle branch block.

Adult↗

[Determination of nicotinic acid in injections by high-performance liquid chromatography].

A high-performance liquid chromatographic method for determination of nicotinic acid (NA) in commercial injections was established. NA was determined by high-performance liquid chromatography on an Inertsil ODS column (4.6 x 150 mm) using a mixture of 0.05M monobasic sodium phosphate solution (pH 3) and methanol (80:20) containing 1.5 mM sodium 1-octanesulfonate as the mobile phase at 35 degrees C and the detection wavelength at 260 nm. The working curve for 0 to 120 micrograms nicotinic acid/ml against 100 micrograms caffeine/ml as internal standard passed through the origin and was linear. On comparing the analytical data obtained by this method and those by the colorimetric method, both data were in good agreement.

Chromatography, High Pressure Liquid↗

[Ergocalciferol Reference Standard (Control 871) of National Institute of Hygienic Sciences].

The Ergocalciferol Reference Standard (Control 871) for the Japanese Pharmacopoeia was prepared. The following analytical data were obtained: melting point, 115.9 degrees C; infrared spectrum, same as the Japanese Pharmacopoeia Standard "Ergocalciferol Standard (Control 851)"; absorbance, E1%1cm (265 nm) = 464.8; optical rotation, [alpha]20D = +104.7 degrees; thin-layer chromatography, same as the Japanese Pharmacopoeia Standard; high-performance liquid chromatography, contaminants were not detected; assay, 101.2%. On the basis of those results, this material was authorized as the Japanese Pharmacopoeia Standard (control 871).

Chemical Phenomena↗

[Diflucortolone-21-valerate Reference Standard (Control 871) of National Institute of Hygienic Sciences].

Diflucortolone-21-valerate was tested for the preparation of "Diflucortolone-21-valerate Reference Standard (Control 871)". Analytical data obtained were as follows: loss on drying, 0.05%; infrared spectrum, 1745, 1727, 1667, 1625, 1611, 1169 cm-1; ultraviolet spectrum, lambda max = 239 nm; absorbance, E1%1cm (239 nm) = 348.8; optical rotation, [alpha]20D: + 100.8 degrees; melting point, 203.2 degrees C; thin-layer chromatography, three contaminants were detected; high-performance liquid chromatography, two contaminants were detected; fluorine, 8.06%. On the basis of those results, this material was authorized as the National Institute of Hygienic Sciences Reference Standard (Control 871).

Chemical Phenomena↗

[Cyanocobalamin Reference Standard (Control 871) of National Institute of Hygienic Sciences].

Cyanocobalamin was tested for the preparation of "Cyanocobalamin Reference Standard (Control 871)". Analytical data obtained were as follows: loss on drying, 11.6%; infrared spectrum, same as that of Cyanocobalamin Reference Standard (Control 861); thin-layer chromatography, two contaminants were detected; high-performance liquid chromatography, seven contaminants were detected; assay, 99.9% by JP XI method and 100.2% by HPLC method in terms of J.P. Reference Standard (Control 861), respectively. On the basis of those results, this material was authorized as the Japanese Pharmacopoeia Standard (Control 871).

Chromatography, High Pressure Liquid↗

[Tocopherol Reference Standard (Control 881) of National Institute of Hygienic Sciences].

Tocopherol was tested for the preparation of "Tocopherol Reference Standard (Control 881)". Analytical data obtained were as follows: infrared spectrum, same as Tocopherol Reference Standard (Control 851); absorbance, E1%1cm (292 nm) = 73.7; thin-layer chromatography, contaminants were not detected until 12.5 micrograms; high-performance liquid chromatography, six contaminants were detected; assay, 100.4%. On the basis of those results, this material was authorized as the Japanese Pharmacopoeia Standard (Control 881).

Chromatography, High Pressure Liquid↗

[Prednisolone Reference Standard of National Institute of Hygienic Sciences].

Prednisolone reference standard for the Japanese Pharmacopoeia was prepared. The quality of raw material was examined and compared with the previous reference standard (Control 821). Analytical data for this substance were as follows: loss on drying, 0.04%; melting point, 234.1 degrees C (decomposition); optical rotation, [alpha] 20D + 100.2 degrees; UV spectrum, lambda max = 243 nm; absorptivity, E1%1cm (243 nm) = 415; IR spectrum, 1711, 1655, 1612, 1111, 899 cm-1; one impurity was detected by TLC and high-performance liquid chromatography (HPLC), respectively; assay by HPLC, 100.1%. Based on the above results, this raw material was authorized as the Reference Standard of National Institute of Hygienic Sciences.

Chemical Phenomena↗

[Pyridoxine Hydrochloride Reference Standard (Control 871) of National Institute of Hygienic Sciences].

The raw material of pyridoxine hydrochloride was examined for the preparation of "Pyridoxine Hydrochloride Reference Standard". Analytical data for the sample were as follows: loss on drying is 0.01%; pH 2.94; melting point 205.2 degrees C (decomposition); IR spectrum same as the Pyridoxine Hydrochloride Reference Standard (Control 801); TLC indicates no impurities; nitrogen is 6.77% (Theoretical value 6.81%); and assay 99.5% by non-aqueous titration, 99.8% by UV spectroscopy, and 100.2% by measuring chloride ion. Based on the above results, this raw material was authorized to be Reference Standard of National Institute of Hygienic Sciences.

Chemical Phenomena↗

[Tocopherol Acetate Reference Standard (Control 881) of National Institute of Hygienic Sciences].

Tocopherol acetate was tested for the preparation of "Tocopherol Acetate Reference Standard (Control 881)". Analytical data obtained were as follows: infrared spectrum, same as Tocopherol Acetate Reference Standard (Control 851); absorbance, E1%1cm (284 nm) = 43.7; thin-layer chromatography, contaminants were not detected; high-performance liquid chromatography, one contaminant was detected; assay, 100.0%. On the basis of those results, this material was authorized as the Japanese Pharmacopoeia Standard (Control 881).

Chromatography, High Pressure Liquid↗